Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Breast Cancer
Sort By
Newest First
1 / 1
1 / 1
Antibody–Drug Conjugates
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Loretta Itri, M.D., F.A.C.P.,; Usama Malik
Immunomedics
PAP-Q2-20-CL-012
Jul 01, 2020
FDA Approval
FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer
U.S. Food & Drug Administration
PR-M07-18-NI-095
Jul 27, 2018
Oncology
Hormone Therapy Appears to Be the Best Bet for Treating Early Breast Cancer
Emilie Branch
Pharma's Almanac
PAO-M06-18-NI-011
Jun 14, 2018
Biosimilar
FDA Recommends Approval of Trastuzumab Biosimilar
Guy Tiene
Nice Insight
PAO-M07-17-NI-025
Jul 21, 2017
FDA
Lilly’s Breast Cancer Treatment Granted Priority Review
Steve Kuehn
Nice Insight
PAO-M07-17-NI-019
Jul 13, 2017